Inhaled Insulin (Exubera)
An inhaled, dry-powder formulation of rapid-acting human insulin (Exubera - Pfizer) has been approved by the FDA for treatment of adults with type 1 or type 2 diabetes....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Inhaled Insulin (Exubera)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1239
Article Code: 1239a
Date: July 17, 2006
Volume: 48
Pages: 57-58
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1239
Article Code: 1239a
Date: July 17, 2006
Volume: 48
Pages: 57-58
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)